Diabetes Leader USV slashes price of its popular Diabetes Medicine JALRA OD
Mumbai: With an aim to make its popular antidiabetic medicine more affordable and accessible to the Indian population, leading pharma company USV Ltd. has now reduced the price of its brand Jalra-OD.
The once daily dosing tablet of JALRA OD which contains Vildagliptin 100mg SR will now be available at price of Rs 13.5 per tablet a sharp reduction from its earlier price of Rs 18 per tablet.
Jalra-OD is the No.1 prescribed brand as per data from healthplix and is trusted by more than 50 thousand patients. Jalra-OD which contains Vildagliptin 100mg SR is a well studied molecule with 90% DPP4 inhibition while the DPP4 inhibition by Sita 100mg is 86.9%. Along with being efficacious Vildagliptin 100mg SR has proven its hepatic and cardiac safety.
Reference: Herman GA, et al. Clinical Pharmacology & Therapeutics. 2005; 78(6):675-88.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.